Skip to content

Vertex Pharmaceuticals VRTX Common stock, shares issued (in shares)

Common stock, shares issued (in shares) at other companies

Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
AbbVie logo
AbbVieABBV
Prime Medicine logo
Prime MedicinePRME
Sionna Therapeutics, Inc. Common Stock logo
Sionna Therapeutics, Inc. Common StockSION

Other financials

Income statement

See full
Revenue$3.0B+7.8%
Gross profit$2.6B+7.8%
Operating income$1.1B+80.6%
Net income$1.0B+59.6%
EPS (diluted)$4.02+61.4%

Balance sheet

See full
Cash & equivalents$5.5B+17.5%
Total debt$2.0B+20.5%
Total equity$19.4B+17.4%
Total assets$26.5B+15.8%

Cash flow

See full
Operating cash flow$1.4B+74.4%
CapEx$133.4M+228%
Free cash flow$1.3B+66.4%

Valuation

See full
Market cap$126.07B+10.7%
Enterprise value$122.55B+11.0%
P/E29.1×
P/S10.3×+0.3×

Profitability

See full
Gross margin86.2%+0.2pp
Operating margin38.3%
Net margin35.5%
FCF margin30.4%+20.2pp

Returns & leverage

See full
Return on equity24.2%
Debt / equity0.1×0.0×
Current ratio+0.4×

Where this comes from

Reported directly by Vertex Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The official record: Vertex Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vertex Pharmaceuticals's common stock, shares issued (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vertex Pharmaceuticals's common stock, shares issued (in shares)?
Vertex Pharmaceuticals (VRTX) reported common stock, shares issued (in shares) of 254.2M in Q1 2026.
How has Vertex Pharmaceuticals's common stock, shares issued (in shares) changed year-over-year?
Vertex Pharmaceuticals's common stock, shares issued (in shares) decreased by 1.1% year-over-year, from 257M to 254.2M.
What is the long-term trend for Vertex Pharmaceuticals's common stock, shares issued (in shares)?
Over 5 years (2020 to 2025), Vertex Pharmaceuticals's common stock, shares issued (in shares) has grown at a -0.5% compound annual growth rate (CAGR), from 259.9M to 254M.